{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T11:32:06Z","timestamp":1794310326336,"version":"4.9.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.ijantimicag.2009.03.009","type":"journal-article","created":{"date-parts":[[2009,4,29]],"date-time":"2009-04-29T09:34:38Z","timestamp":1240997678000},"page":"111-120","source":"Crossref","is-referenced-by-count":158,"title":["Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies"],"prefix":"10.1016","volume":"34","author":[{"given":"Matthew E.","family":"Falagas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia C.","family":"Kastoris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drosos E.","family":"Karageorgopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros I.","family":"Rafailidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2009.03.009_bib1","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.ijantimicag.2006.12.012","article-title":"Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?","volume":"29","author":"Falagas","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib2","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1586\/14787210.6.5.593","article-title":"Potential of old-generation antibiotics to address current need for new antibiotics","volume":"6","author":"Falagas","year":"2008","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib3","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0140-6736(06)68241-X","article-title":"Polymyxins: old antibiotics are back","volume":"367","author":"Falagas","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/jac\/dkn165","article-title":"Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence","volume":"62","author":"Karageorgopoulos","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib5","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1749-6632.1974.tb43277.x","article-title":"The mechanism of action of fosfomycin (phosphonomycin)","volume":"235","author":"Kahan","year":"1974","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib6","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/jac\/34.6.853","article-title":"Fosfomycin trometamol","volume":"34","author":"Reeves","year":"1994","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib7","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1086\/527442","article-title":"Fosfomycin: use beyond urinary tract and gastrointestinal infections","volume":"46","author":"Falagas","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib8","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10096-007-0456-4","article-title":"Antimicrobial susceptibility of multidrug-resistant Gram negative bacteria to fosfomycin","volume":"27","author":"Falagas","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jhin.2007.10.016","article-title":"Long-term evolution of a nosocomial outbreak of Pseudomonas aeruginosa producing VIM-2 metallo-enzyme","volume":"68","author":"Corvec","year":"2008","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib10","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.medmal.2008.03.002","article-title":"Fosfomycin prescription during production shortage","volume":"38","author":"Dinh","year":"2008","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib11","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ijantimicag.2007.07.023","article-title":"Antimicrobial activity of fosfomycin against multidrug-resistant Pseudomonas aeruginosa in vitro","volume":"30","author":"Kobayashi","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib12","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1469-0691.2006.1532_1.x","article-title":"Emergence of carbapenem-hydrolysing metallo-\u03b2-lactamase VIM-1 in Pseudomonas aeruginosa isolates in France","volume":"12","author":"Corvec","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib13","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1469-0691.2006.01530.x","article-title":"Genotypic diversity and antibiotic susceptibility of Acinetobacter baumannii isolates in a Bulgarian hospital","volume":"12","author":"Dobrewski","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib14","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/jac\/dkl266","article-title":"Characterization of acquired \u03b2-lactamases and their genetic support in multidrug-resistant Pseudomonas aeruginosa isolates in Taiwan: the prevalence of unusual integrons","volume":"58","author":"Yan","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib15","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1128\/JCM.43.8.4129-4138.2005","article-title":"Prolonged outbreak of infection due to TEM-21-producing strains of Pseudomonas aeruginosa and enterobacteria in a nursing home","volume":"43","author":"Dubois","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib16","first-page":"1239","article-title":"In vitro activity of fosfomycin\u2013gentamicin, fosfomycin\u2013ceftazidime, fosfomycin\u2013imipenem and ceftazidime\u2013gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa","volume":"36","author":"Pruekprasert","year":"2005","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib17","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1128\/JCM.42.9.3978-3984.2004","article-title":"Nosocomial transmission of CTX-M-2 \u03b2-lactamase-producing Acinetobacter baumannii in a neurosurgery ward","volume":"42","author":"Nagano","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s101560200004","article-title":"Effectiveness of fosfomycin combined with other antimicrobial agents against multidrug-resistant Pseudomonas aeruginosa isolates using the efficacy time index assay","volume":"8","author":"Okazaki","year":"2002","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s100960050320","article-title":"Carbapenem-hydrolyzing metallo-\u03b2-lactamases in Pseudomonas aeruginosa","volume":"18","author":"Mazzariol","year":"1999","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib20","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1128\/JB.183.1.235-249.2001","article-title":"Characterization of In53, a class 1 plasmid- and composite transposon-located integron of Escherichia coli which carries an unusual array of gene cassettes","volume":"183","author":"Naas","year":"2001","journal-title":"J Bacteriol"},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib21","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000007121","article-title":"Surveillance of Pseudomonas aeruginosa in intensive care units: clusters of nosocomial cross-infection and encounter of a multiple-antibiotic resistant strain","volume":"44","author":"Traub","year":"1998","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/jac\/39.2.169","article-title":"Isolation from clinical sources of Burkholderia cepacia possessing characteristics of Burkholderia gladioli","volume":"39","author":"Baxter","year":"1997","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl. 6","key":"10.1016\/j.ijantimicag.2009.03.009_bib23","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0399-077X(97)80220-X","article-title":"Outbreak of nosocomial infections due to serotype O11 multiresistant Pseudomonas aeruginosa","volume":"27","author":"Salauze","year":"1997","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF01709477","article-title":"In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa","volume":"16","author":"Tessier","year":"1997","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib25","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/jac\/37.4.809","article-title":"Comparative distribution of resistance patterns and serotypes in Pseudomonas aeruginosa isolates from intensive care units and other wards","volume":"37","author":"Bert","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib26","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1128\/JCM.34.12.3226-3229.1996","article-title":"Molecular epidemiology provides evidence of genotypic heterogeneity of multidrug-resistant Pseudomonas aeruginosa serotype O:12 outbreak isolates from a pediatric hospital","volume":"34","author":"Bingen","year":"1996","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib27","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/jac\/38.6.1107","article-title":"In-vitro activity of antimicrobial agent combinations against multiresistant Acinetobacter baumannii","volume":"38","author":"Martinez-Martinez","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib28","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/BF01691312","article-title":"Study of Pseudomonas aeruginosa serotype O12 isolates with a common antibiotic susceptibility pattern","volume":"15","author":"Talarmin","year":"1996","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib29","first-page":"293","article-title":"Susceptibility of multiresistant serotype O12 Pseudomonas aeruginosa to fosfomycin in combination with other antibiotics","volume":"42","author":"Watine","year":"1994","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib30","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/BF00141801","article-title":"Infections caused by Pseudomonas aeruginosa: relatively frequent isolation of serogroup 12 from clinical specimens","volume":"1","author":"Giammanco","year":"1985","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib31","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1128\/AAC.39.2.496","article-title":"Comparative efficacies of ciprofloxacin and pefloxacin alone or in combination with fosfomycin in experimental endocarditis induced by multidrug-susceptible and -resistant Pseudomonas aeruginosa","volume":"39","author":"Xiong","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib32","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ijantimicag.2008.05.010","article-title":"Fosfomycin for Pseudomonas-related exacerbations of cystic fibrosis","volume":"32","author":"Faruqi","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib33","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jcf.2006.08.003","article-title":"Fosfomycin\u2014investigation of a possible new route of administration of an old drug. A case study","volume":"6","author":"Cree","year":"2007","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib34","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/jac\/dki280","article-title":"Bacterial prostatitis due to Pseudomonas aeruginosa harbouring the blaVIM-2 metallo-\u03b2-lactamase gene from Saudi Arabia","volume":"56","author":"Guerin","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib35","first-page":"89","article-title":"Combination treatment of piperacillin\/tazobactam, amikacin and fosfomycin for probable multidrug-resistant Pseudomonas aeruginosa infection: a case report","volume":"21","author":"Waiwarawooth","year":"2004","journal-title":"J Infect Dis Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1569-1993(02)00143-1","article-title":"Fosfomycin therapy for multiresistant Pseudomonas aeruginosa in cystic fibrosis","volume":"2","author":"Mirakhur","year":"2003","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib37","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF02014882","article-title":"Fosfomycin in the treatment of cystic fibrosis","volume":"3","author":"Katznelson","year":"1984","journal-title":"Eur J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib38","first-page":"472","article-title":"Sensitivity to fosfomycin of multiresistant serotype O12 Pseudomonas aeruginosa. Multicenter study [in French]","volume":"45","author":"Dubrous","year":"1997","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib39","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Eighteenth informational supplement. Document M100-S18. Wayne, PA: CLSI; 2008."},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib40","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1128\/AAC.39.5.1038","article-title":"Combination effect of fosfomycin and ofloxacin against Pseudomonas aeruginosa growing in a biofilm","volume":"39","author":"Kumon","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib41","first-page":"209","article-title":"Synergistic effect of fosfomycin and fluoroquinolones against Pseudomonas aeruginosa growing in a biofilm","volume":"59","author":"Mikuniya","year":"2005","journal-title":"Acta Med Okayama"},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib42","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/jac\/34.1.165","article-title":"The incidence of serotype O12 and multiresistance amongst Pseudomonas aeruginosa clinical isolates","volume":"34","author":"Patzer","year":"1994","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib43","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1017\/S095026880003096X","article-title":"Multiresistant serotype O12 Pseudomonas aeruginosa: evidence for a common strain in Europe","volume":"103","author":"Pitt","year":"1989","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib44","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000100811","article-title":"Role of ciprofloxacin in its synergistic effect with fosfomycin on drug-resistant strains of Pseudomonas aeruginosa","volume":"53","author":"Yamada","year":"2007","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib45","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/jac\/dkn174","article-title":"Beta-lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres)","volume":"62","author":"Dubois","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib46","unstructured":"British Society for Antimicrobial Chemotherapy. BSAC methods for antimicrobial susceptibility testing, Version 7, January 2008. BSAC; 2008. http:\/\/www.bsac.org.uk\/_db\/_documents\/version_7.pdf [accessed 17 March 2009]."},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib47","unstructured":"Comit\u00e9 de l\u2019Antibiogramme de la Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie. Recommandations 2008 (Edition de Janvier 2008). CA-SFM; 2008. http:\/\/www.sfm.asso.fr\/ [accessed 17 March 2009]."},{"key":"10.1016\/j.ijantimicag.2009.03.009_bib48","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1086\/528867","article-title":"Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology","volume":"46","author":"Falagas","year":"2008","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857909001344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857909001344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T20:26:10Z","timestamp":1589747170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857909001344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0924857909001344"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2009.03.009","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}